Rafael Amado Net Worth & Insider Trades
Rafael Amado - EVP R&D, Allogene Therapeutics, Inc
What is Rafael Amado's Net Worth?
The current estimated net worth of Allogene Therapeutics, Inc's EVP R&D, Rafael Amado, is estimated to be about $6.59M . Rafael Amado owns about 540,257 units of Allogene Therapeutics, Inc common stock. In the last 3 years at Allogene Therapeutics, Inc, Rafael Amado has sold an estimated value of $1.79M worth.
What is Rafael Amado's Past Insider Trading?
Rafael Amado's largest sale order was 16,538 units , worth over $651.51K on October 8, 2020. In total, Rafael Amado has made about 16 transactions over 3 years of their time at Allogene Therapeutics, Inc. Rafael Amado usually trades in March and October, with the busiest year in 2022. The most recent transaction was a sale order of 2,000 units , worth over $23.94K on August 2, 2022.
Rafael Amado
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Rafael Amado's Salary in 2020?
As EVP R&D of Allogene Therapeutics, Inc, Rafael Amado has a total base salary of $510,000 . Rafael Amado received compensation valued at about $2,663,819 in 2020 after becoming EVP R&D. The vast majority of their compensation came in the form of a bonus of $75,000 , stock awards of $561,176 , option awards of $1,262,643 , other earnings, plans or compensations of $255,000 , and
What is Rafael Amado's' Mailing Address?
- Mailing address is 5 Ashwood Lane Malvern PA 19435 PA
Allogene Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| David Chang, M.D., Ph.D. | 2020 | $675,000 | - | - | $6,550,535 | $506,250 | $83,256 | $7,815,041 |
| David Chang, M.D., Ph.D. | 2019 | $600,000 | - | $4,651,970 | $5,327,140 | $363,000 | $250,000 | $11,192,110 |
| David Chang, M.D., Ph.D. | 2018 | $362,413 | - | $8,948,152 | $3,070,331 | $217,641 | $250,000 | $12,848,537 |
| Eric Schmidt, Ph.D. | 2020 | $440,000 | - | $561,176 | $1,262,643 | $220,000 | - | $2,483,819 |
| Eric Schmidt, Ph.D. | 2019 | $425,000 | - | $1,328,366 | $1,519,700 | $187,000 | - | $3,460,066 |
| Eric Schmidt, Ph.D. | 2018 | $201,232 | - | - | $2,299,658 | $88,099 | - | $2,588,989 |
| Rafael Amado, M.D. | 2020 | $510,000 | $75,000 | $561,176 | $1,262,643 | $255,000 | - | $2,663,819 |
| Rafael Amado, M.D. | 2019 | $145,833 | - | $4,249,976 | $2,759,623 | $71,726 | $225,000 | $7,452,158 |
| Alison Moore, Ph.D. | 2020 | $440,000 | - | $561,176 | $1,262,643 | $220,000 | - | $2,483,819 |
| Alison Moore, Ph.D. | 2019 | $425,000 | - | $996,275 | $1,519,700 | $187,000 | - | $3,127,975 |
| Alison Moore, Ph.D. | 2018 | $233,265 | - | - | $1,401,225 | $102,124 | $100,000 | $1,836,614 |
| Veer Bhavnagri | 2020 | $425,000 | - | $537,490 | $1,211,953 | $212,500 | $9,385 | $2,396,328 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1737287/000173728721000013/allo-20210423xdef14axproxy.htm
What are Allogene Therapeutics, Inc's Past Insider Trades?
Allogene Therapeutics, Inc's most recent insider trade came on February 14, 2023 by Veer Bhavnagri who sold 3,000 units worth $20.55K . In the last 5 years, insiders at Allogene Therapeutics, Inc have sold an estimated value of $153.1M and bought an estimated value of $33.14M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are David Chang, President and CEO, Veer Bhavnagri, General Counsel, and Alison Moore, Chief Technical Officer .
Allogene Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||